Interview with Olivier Daubry, General Manager, Celgene France
In only four years Celgene has introduced a number of important products in the French market and is now seen as a preeminent biopharmaceutical company in hematology. As the head…
Shire serves as an industry leader in research and treatments of rare and orphan diseases, allowing patients with severe conditions to lead better lives. The company’s deep understanding of patients and their needs enables them to develop and deliver health care in therapeutic areas including, behavioral disorders and gastrointestinal diseases, as well as other symptomatic conditions followed by specialists. Shire upholds an ambition to imagine the future and be at the forefront of health care in creating value for patients, physicians, policymakers, payers and shareholders. Shire France is the French subsidiary of Shire Pharmaceuticals Group plc based in the UK and the US. As the operator of specialty pharmaceuticals and as such, its products are sold by the conventional circuit of distribution: custodians, distributors, pharmaceutical wholesale distributors, pharmacies, care facilities. The French affiliate specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, genetic diseases.
In only four years Celgene has introduced a number of important products in the French market and is now seen as a preeminent biopharmaceutical company in hematology. As the head…
Octapharma was founded in 1983 and entered decisively in the French market in 1999, when it acquired a plasma facility in Lingolsheim, Alsace. Since then, what have been the main…
As the market leader in the French pre-wholesale market, Depolado had a quite impressive market share growth in the previous 3 years, now being responsible for a quarter of the…
This year Menarini will launch several new products in France to add to its current portfolio. Apart from this, can you tell us about activities and position in France? Our…
The basis of the pharmaceutical business model is changing. Take sales forces for instance, what will be the composition and daily routine? How much mixed media will it require? Currently,…
There is a lot of activity in the pharmaceutical industry and France is no exception especially having passed Germany as the major market of Europe over the past year which…
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart…
Can you highlight some of the more recent milestones for Stallergenes? Stallergenes has been successful over recent years for several reasons, the first of which is the growth of the…
As Quintiles is present in all major pharmaceutical markets worldwide, what’s the relevance of the French affiliate and what role it plays inside such a globalized organization? France is important…
When we met your Italian colleague, he noted that they had tripled their turnover in a five year period. You haven’t done badly yourself in the relatively short period of…
Biogaran was an initiative from Servier in the mid 1990s before there was even a generic pharmaceutical market in France. Could you speak of your history and of the origins…
See our Cookie Privacy Policy Here
